We investigate new products (drugs, nutraceuticals, etc.) or medical technologies in patients. They are a fundamental instrument for transferring new scientific knowledge to clinical practice to improve the quality of life of patients with osteoarthritis.

At OAFI we are currently collaborating in four new clinical trials:

  • E.C.C .: A new injectable treatment for osteoarthritis of the knee in a population with osteoarthritis of the knee.

 

  • E.C.C .: Food supplementation for the treatment of chronic pain in osteoarthritis of the knee

 

  • E.C.C: A drug for the improvement of hand osteoarthritis, a pathology for which, to date, there are no specific treatments.

 

  • ECC: Use of a new technology for the diagnosis of the degree of osteoarthritis in an objective and quantifiable way.

 

If you want to receive more information or if you want to participate in these studies, contact us by writing an email to info@oafifoundation.com

Testimonial de OAFI

“What it represents to be a volunteer for OAFI is just to think about the welfare of others and at the same time feel immensely pleased and satisfied seeing the improvements that can be reached by everyone.

OAFI is a window of fresh air, full of hope for a future without much suffering because of osteoarthritis.”

ANNA ARTAU

Help us improve the quality of life of osteoarthritis patients